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BACKGROUND AND PURPOSE: Post hoc analyses of randomized controlled clinical trials evaluating mechanical thrombectomy 
have suggested that admission-to-groin-puncture (ATG) delays are associated with reduced reperfusion rates. Purpose 
of this analysis was to validate this association in a real-world cohort and to find associated factors and confounders for 
prolonged ATG intervals.
METHODS: Patients included into the BEYOND-SWIFT cohort (Bernese-European Registry for Ischemic Stroke Patients 
Treated Outside Current Guidelines With Neurothrombectomy Devices Using the Solitaire FR With the Intention for 
Thrombectomy; https://www.clinicaltrials.gov; Unique identifier: NCT03496064) were analyzed (n=2386). Association 
between baseline characteristics and ATG was evaluated using mixed linear regression analysis. The effect of increasing 
symptom-onset-to-admission and ATG intervals on successful reperfusion (defined as Thrombolysis in Cerebral Infarction 
[TICI] 2b-3) was evaluated using logistic regression analysis adjusting for potential confounders.
RESULTS: Median ATG was 73 minutes. Prolonged ATG intervals were associated with the use of magnetic resonance imaging 
(+19.1 [95% CI, +9.1 to +29.1] minutes), general anesthesia (+12.1 [95% CI, +3.7 to +20.4] minutes), and borderline indication 
criteria, such as lower National Institutes of Health Stroke Scale, late presentations, or not meeting top-tier early time window 
eligibility criteria (+13.8 [95% CI, +6.1 to +21.6] minutes). There was a 13% relative odds reduction for TICI 2b-3 (adjusted odds 
ratio [aOR], 0.87 [95% CI, 0.79–0.96]) and TICI 2c/3 (aOR, 0.87 [95% CI, 0.79–0.95]) per hour ATG delay, while the reduction 
of TICI 2b-3 per hour increase symptom-onset-to-admission was minor (aOR, 0.97 [95% CI, 0.94–0.99]) and inconsistent 
regarding TICI 2c/3 (aOR, 0.99 [95% CI, 0.97–1.02]). After adjusting for identified factors associated with prolonged ATG 
intervals, the association of ATG delay and lower rates of TICI 2b-3 remained tangible (aOR, 0.87 [95% CI, 0.76–0.99]).
CONCLUSIONS: There is a great potential to reduce ATG, and potential targets for improvement can be deduced from 
observational data. The association between in-hospital delay and reduced reperfusion rates is evident in real-world clinical 
data, underscoring the need to optimize in-hospital workflows. Given the only minor association between symptom-onset-to-
admission intervals and reperfusion rates, the causal relationship of this association warrants further research.
REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT03496064.
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Achieving successful and ideally complete reper-fusion is the most important modifiable predictor of good outcome in patients with acute ischemic 
stroke undergoing mechanical thrombectomy.1–4 A 
recent analysis of the HERMES (Highly Effective Reper-
fusion Evaluated in Multiple Endovascular Stroke Trials) 
collaboration suggested that the chances of achieving 
reperfusion decrease with prolonged admission-to-groin 
(ATG) intervals, with an estimated relative decrease in 
the odds of successful reperfusion of 22% per hour of 
in-hospital delay.5
No significant effect on successful reperfusion was 
found for symptom-onset-to-groin-puncture (STG) 
intervals, however.5 This discrepancy was attributed 
mostly to the strict inclusion criteria of the random-
ized controlled trials and uncertainties regarding the 
precision of the symptom onset, hence diluting a pos-
sibly significant effect of time elapsed from symptom 
onset.5
In the current study, we aimed to quantify the effect 
of symptom-to-admission (STA), ATG, and STG inter-
vals on rates of successful reperfusion in a real-world 
registry with less restrictive inclusion criteria and 
performed explorative analysis regarding potential 
confounders.
METHODS
The data that support the findings of this study are available 
from the corresponding author upon reasonable request and 
after clearance by the local ethics committee.
BEYOND-SWIFT Registry
The BEYOND-SWIFT (Bernese-European Registry for 
Ischemic Stroke Patients Treated Outside Current Guidelines 
With Neurothrombectomy Devices Using the Solitaire FR With 
the Intention for Thrombectomy) is an investigator-initiated, 
international, multicenter observational registry evaluating the 
outcome of mechanical thrombectomy patients (https://www.
clinicaltrials.gov; Unique identifier: NCT03496064). Details 
of the registry have been published previously.6 In short, 7 
comprehensive stroke centers included patients treated with 
a Medtronic market-released neurothrombectomy device 
(applied as first-line device) for patients presenting with large 
vessel occlusion acute ischemic stroke. Table I in the Data 
Supplement provides an overview of included patients and rates 
of available follow-up data for each center. Written informed 
consent was obtained from patients, or the institutional review 
board waived the need for patient consent, according to regu-
lations at each center/country (Table I in the Data Supplement). 
In Bern, ethical approval was given for pooling and analysis 
of the registry data (Kantonale Ethikkommission Bern, Bern, 
Switzerland; Local Ethics Committee Study Identifier: 2018-
00766). For the present analysis, we also included 437 
patients from another German center.7
Of 2397 patients included into the registry, 2127 were 
treated for anterior circulation large vessel occlusion strokes. 
Of these, there were 1953 patients with full documentation of 
STA, ATG, and STG, and 1949 had available angiography runs 
to evaluate reperfusion success. Using the same selection cri-
teria for the additional German center, of 547 patients, 437 
were included.
Variables and Outcomes
Site of occlusion was classified into intracranial internal carotid 
artery, carotid T/L, and first/second segment of the middle 
cerebral artery. Reperfusion success was evaluated applying 
the extended Thrombolysis in Cerebral Infarction (TICI) scale 
with TICI 2b defined as ≥50% reperfusion of the initially hypo-
perfused target territory and TICI 2c defined as “near-complete 
perfusion except for slow flow in a few distal cortical vessels or 
presence of small distal cortical emboli.”8,9 Reperfusion success 
was rated by an independent research fellow or was opera-
tor adjudicated depending on the centers’ standards. Alberta 
Stroke Program Early CT Scores (ASPECTS) were evaluated 
on noncontrast admission computed tomography images or 
diffusion-weighted imaging–based ASPECTS when patients 
underwent magnetic resonance imaging (MRI). Slow and fast 
progressors were dichotomized according to a median split of 
ASPECTS decay (estimated as ASPECTS regions infarcted/
time from STA). Interventional characteristics were recorded 
including interventional technique, maneuver count, interven-
tional complications, and time from groin puncture to reper-
fusion. Functional outcome was assessed at 3 months after 
the index event using the modified Rankin Scale (mRS), with 
mRS ≤2 defined as good functional outcome. Symptomatic 
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intracranial hemorrhage was defined according to ECASS-II 
(European Co-Operative Acute Stroke Study-II) definition.10 
Primary outcome of this analysis was the rate of TICI 2b-3 with 
strata of ATG intervals. Secondary outcomes were the evalua-
tion of a potential association between STA and STG and rates 
of TICI 2b-3. Explorative analyses were performed regarding 
rates of TICI 2c/3, rates of first-pass TICI 2c/3, periprocedural 
complications, utilizing >3 maneuvers, and occurrence of symp-
tomatic intracranial hemorrhage with strata of ATG intervals.
Descriptive Statistics
Continuous variables are presented as mean±SD or median 
and interquartile range (IQR). Frequency counts are shown as 
percentage and n/N.
Logistic Regression Analysis
The effect of STA, ATG, and STG on TICI 2b-3 was evaluated 
using multivariate binary logistic regression analysis with STA/
ATG included as continuous predictor variable and TICI 2b-3 
as outcome variable. Mixed logistic regression analyses with 
random effects were omitted because preanalysis did not 
provide evidence for model superiority against simple logis-
tic regression analysis (Table II in the Data Supplement). In 
the first logistic regression model (model A), analyses were 
adjusted for age, sex, occlusion location (categorical variable: 
intracranial internal carotid artery/carotid T/L as reference 
versus M1 versus M2), and treatment with intravenous tPA 
(tissue-type plasminogen activator), as described previously.5 
Subgroup analyses were conducted for slow versus fast pro-
gressor in STA analyses and for computed tomography ver-
sus MRI in ATG analyses, utilizing interaction terms. Modeled 
predicted probabilities of TICI 2b-3 with increasing STA or 
ATG were displayed treating all other variables in the model 
at mean (continuous variables) or at balance (categorical vari-
ables). In model B, we incorporated all variables associated 
with ATG from the analysis outlined below together with stroke 
etiologic cause (according to the Trial of ORG 10172 in Acute 
Stroke Treatment criteria), interventional technique,11 and year 
of patient treatment (see Table III in the Data Supplement for a 
model overview). We also ran an additional sensitivity analysis 
including periprocedural complications and number of maneu-
vers into the model (model B*). All logistic regression models 
are adjusted for center. Outputs of logistic regression analy-
ses are generally displayed as adjusted odds ratio (aOR) per 
60-minute increase and corresponding 95% CIs.
Mixed Linear Regression Analysis
To find associations between baseline characteristics and pro-
longed ATG intervals, a mixed linear regression analysis was 
performed because a log-likelihood test revealed improved 
model fit as opposed to a simple linear regression model. Age, 
sex, direct admission versus transfer, functional dependence 
(mRS score >2) before the index event, admission National 
Institutes of Heath Stroke Scale (NIHSS) scores, STA, imag-
ing modality, ASPECTS, intracranial occlusion, tandem occlu-
sion, general anesthesia, intravenous tPA treatment, and 
year of treatment were included in the model. Alternatively, 
we implemented treatment eligibility according to early time 
window American Heart Association (AHA)/American Stroke 
Association (ASA) criteria, omitting variables included into eli-
gibility criteria (age, admission NIHSS, etc). Early time window 
eligibility according to AHA/ASA criteria was defined as a 
compound criterion of meeting prestroke mRS score <2, inter-
nal carotid artery or M1 occlusion, age >18 years, NIHSS ≥6, 
ASPECTS ≥6, and time to groin ≤6 hours.12 Center site was 
implemented as a random-effects variable.
Significance level was set to α=0.05. All tests are 2 sided. 




Two thousand three hundred eighty-six patients were 
included (median age, 74.7 years; IQR, 62.2–82.0; 
51.2% women; Table 1), of which 2008 (84.2%) were 
successfully reperfused (TICI 2b-3, including 54.4% with 
TICI 2c/3 reperfusions). Rates of successful reperfusion 
and TICI 2c/3 differed across centers (Figure I in the 
Data Supplement) and by year of patient treatment (odds 
ratio per year increase after 2015, 1.16 [95% CI, 1.05–
1.28]; Figure II in the Data Supplement). Additionally, we 
observed an association between interventional tech-
nique applied and reperfusion success, with the highest 
rates of successful reperfusion or TICI 2c/3 observed in 
patients treated with stent retriever and a balloon guide 
catheter (Figure III in the Data Supplement). Median STA 
delay was 150 minutes (IQR, 72–265 minutes), whereas 
median ATG interval was 73 minutes (IQR, 47–102 min-
utes). The relative percentage of ATG from STG was 
33.0% (IQR, 16.4%–52.6%). Occlusion site was mostly 
M1 (57.2%, 1365 of 2386), followed by intracranial 
internal carotid artery/carotid T/L (26.2%, 625 of 2386) 
and M2 occlusions (16.6%, 396 of 2386).
Effect of STA and ATG on Successful 
Reperfusion
Overall, there was a small reduction in the likelihood 
of achieving TICI 2b-3 with increasing STA (aOR, 0.97 
[95% CI, 0.94–0.99] per hour; Table 2; Figure 1A). This 
association appeared stronger in fast progressors (aOR, 
0.86 [95% CI, 0.79–0.95] per hour), without reaching 
statistical significance on interaction analysis (P for inter-
action, 0.081). With increasing ATG, there was a strong 
reduction in the rates of TICI 2b-3 (aOR, 0.87 [95% CI, 
0.79–0.96] per hour; Figure 1C), corresponding to a 
13% reduction in the odds of TICI 2b-3 per in-hospital 
hour delay. This association appeared more pronounced 
in patients undergoing MRI (aOR, 0.77 [95% CI, 0.65–
0.91]), without reaching significance on interaction anal-
ysis (P for interaction, 0.102).
For ATG, these association remained unchanged 
when considering TICI 2c/3 as relevant interventional 
end point (aOR, 0.87 [95% CI, 0.79–0.95]; Figure 1C), 
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while no significant association of STA with rates of 
TICI 2c/3 was found (aOR, 0.99 [95% CI, 0.97–1.02]; 
Figure 1A).
For STG intervals, a significant association with TICI 
2b-3 was found (Figure 1B), but this was partially attrib-
uted to the association of ATG intervals with TICI 2b-3 
(see STG* in Table 2).
Association of ATG With Secondary 
Interventional Outcomes
Every hour decrease in ATG was associated with 
reduced rates of first-pass TICI 2c/3 (aOR, 0.87 [95% 
CI, 0.77–0.98]). There was no statistically significant 
association of ATG with other interventional charac-
teristics, including complications, rates of symptomatic 
intracranial hemorrhage, and utilization of >3 maneu-
vers (Figure 2).
Factors Associated With ATG
Of 2386 patients, 2240 were included in the random-
effects linear regression analysis for identifying fac-
tors associated with ATG (Figure 3A and 3B). Transfer 
admissions (−28.1 [95% CI, −37.2 to −19.1] minutes), 
computed tomography versus MRI (−10.3 [95% CI, 
−21.4 to +0.8] minutes in the model without the com-
pound AHA/ASA eligibility variable and −19.1 [95% 
CI, −29.1 to −9.1] minutes in the model with the com-
pound AHA/ASA eligibility variable), higher admission 
NIHSS (−1.5 minutes per point increase [95% CI, 
−2.3 to −0.8 minutes]), and patient treatment in recent 
years (−15.3 minutes per year increase since 2015 
[95% CI, −19.3 to −11.4 minutes]) were associated 
with shorter ATG intervals. In contrary, late presentation 
(+2.6 minutes per minute presentation delay [95% CI, 
+1.5 to +3.6 minutes]) and use of general anesthesia 
(+18.7 [95% CI, 8.4–29.0] minutes) were associated 
with longer ATGs. Implementing the AHA/ASA eligibil-
ity criteria to the model, conformance with the AHA/
ASA early time window eligibility criteria was associ-
ated with shorter ATG intervals (−13.8 [95% CI, −21.6 
to −6.1] minutes; Figure 3C).
Sensitivity Analyses Utilizing Refined Models 
for the Effect of ATG
We included 1822 of 2386 patients in the refined 
model B. When incorporating factors associated with 
prolonged ATG intervals, together with adjustment for 
stroke etiology, year of patient inclusion, and interven-
tional technique, the effect of ATG on rates of TICI 
2b-3 could still be detected, yielding a 13% relative 
decrease in the odds of TICI 2b-3 per hour of ATG 
delay (aOR, 0.87 [95% CI, 0.76–0.99]; Figure 4). Addi-
tionally implementing the number of maneuvers and 
periprocedural complications as covariates did not sig-
nificantly change this association (model B*; aOR, 0.74 
[95% CI, 0.59–0.92]).
Table 1. Study Cohort
Variable n=2386
Baseline Characteristics
 Age, y 74.7 (62.2–82.0)
 Sex, female 51.2% (1221)
 Admission NIHSS (n=2361/2386) 16 (11–20)
 STA/last seen well to admission, min 150 (72–265)
 Admission imaging, MRI (n=2355/2386) 28.8% (679/2355)
 IV tPA (n=2385/2386) 49.3% (1175/2385)
 Risk factors
  Diabetes mellitus (n=2352/2386) 19.5% (459/2352)
  Hypertension (n=2354/2386) 70.3% (1656/2354)
  Smoking (n=2291/2386) 24.7% (567/2291)
  Dyslipidemia (n=2344/2386) 50.6% (1186/2344)




  Intracranial ICA 4.0% (95)
  Carotid T/L-type occlusion 22.2% (530)
  M1 57.2% (1365)
  M2 16.6% (396)
 Tandem occlusion (n=2383/2386) 16.5% (394/2386)




  Large-artery atherosclerosis 12.5% (293/2338)
  Cardioembolism 47.6% (1112/2338)
  Other determined etiology 9.9% (231/2338)
  Undetermined etiology 30.0% (702/2338)
Procedural characteristics
 ATG, min 73 (47–102)
 Groin puncture to reperfusion 
(n=2193/2386), min
43 (29–70)
 Successful reperfusion 84.2% (2008/2386)
 TICI 2c/3 54.4% (1298/2386)
 First-pass TICI 2c/3 (n=2184/2386) 31.1% (680/2184)
 Maneuver count >3 (n=1905/2386) 11.6% (221/1905)
 Intracranial stenting (n=1947/2386) 2.3% (44/1947)
 Cervical stenting (n=2383/2386) 12.3% (292/2383)
Outcome/safety
 mRS score of 0–2 at day 90 (n=2127/2386) 42.7% (909/2127)
 Mortality at day 90 (n=2127/2386) 26.9% (572/2127)
 sICH (n=2365/2386) 5.7% (135/2365)
Data are displayed in median (IQR) or percentage (n/N). ATG indicates admission-
to-groin-puncture; carotid T/L, T- or L-type occlusion of the carotid terminus; 
ICA, internal carotid artery; IQR, interquartile range; IV tPA, intravenous tissue-type 
plasminogen activator; M1, first segment of the middle cerebral artery; M2, second 
segment of the middle cerebral artery; MRI, magnetic resonance imaging; mRS, 
modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; sICH, 
symptomatic intracranial hemorrhage; STA, symptom-to-admission; TICI, Thrombolysis 
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Clinical Outcomes With Respect to Admission 
to Reperfusion Intervals
There was a 19% relative odds reduction in achieving mRS 
score of 0 to 2 for every hour in-hospital delay (aOR, 0.81 
[95% CI, 0.73–0.90]). There was no interaction regarding 
this effect and occlusion site (P=0.64) or AHA/ASA guide-
line eligibility (P=0.51). This effect was less pronounced 
when considering the time elapsed from symptom onset 
(aOR per hour delay, 0.96 [95% CI, 0.93–0.99]).
DISCUSSION
This registry analysis has the following main findings: 
(1) the association of a reduced rate of TICI 2b-3 with 
increasing ATG is evident in real-world clinical data with 
Table 2. Logistic Regression Analysis With STA/ATG as Predictor Variable and TICI 2b-3 as Outcome Variable
Predictor Variable for TICI 2b-3 Subgroup N Included in the Model aOR (95% CI) P Value Interaction (P Value)
STA  2385 0.97 (0.94–0.99) 0.011 0.081
 Slow progressors* 1093 0.96 (0.93–0.99) 0.009
 Fast progressors 1093 0.86 (0.79–0.95) 0.003
ATG  2385 0.87 (0.79–0.96) 0.007 0.102
 CT† 1675 0.92 (0.81–1.04) 0.114
 MRI 679 0.77 (0.65–0.91) 0.003
STG  2385 0.96 (0.94–0.98) 0.001
STG‡  2385 0.97 (0.95–0.99) 0.033
aORs were calculated using the binary logistic regression model A outlined in Methods. aORs are displayed as per 60-min increase in STA/ATG. aOR indicates 
adjusted odds ratio; ASPECTS, Alberta Stroke Program Early CT Score; ATG, admission-to-groin-puncture; CT, computed tomography; MRI, magnetic resonance imaging; 
STA, symptom-to-admission; STG, symptom-onset-to-groin puncture (ie, STA+ATG); and TICI, Thrombolysis in Cerebral Infarction.
*For 199 patients, infarct progression using STA and ASPECTS could not be calculated.
†For 31 patients, information on admission imaging modality was missing.
‡Additionally corrected for ATG intervals.
Figure 1. Association of symptom-onset-to-admission (STA) and admission-to-groin-puncture (ATG) intervals with the 
probability of achieving Thrombolysis in Cerebral Infarction (TICI) 2b-3 or 2c/3.
Adjusted predicted probabilities of TICI 2b-3 or 2c/3 according to STA, symptom-onset-to-groin puncture (STG), and ATG intervals in minutes 
(see Methods). A, A small association of increasing STA with decreasing odds of achieving TICI 2b-3 was found (adjusted odds ratio [aOR], 0.96 
[95%, 0.94–0.99] per hour) while no statistically significant association between STA and the odds of achieving TICI 2c/3 was observed (aOR, 
0.99 [95% CI, 0.97–1.02] per hour). B, A small association of increasing STG with decreasing odds of achieving TICI 2b-3 was found (aOR, 0.96 
[95%, 0.94–0.99] per hour). C, With increasing ATG, there was a strong reduction in the rates of TICI 2b-3 (aOR, 0.87 [95% CI, 0.79–0.96] per 
hour), corresponding to a 13% reduction in the odds of TICI 2b-3 per in-hospital hour delay. This association was also stable when considering 
TICI 2c/3 as relevant end point (aOR, 0.87 [95% CI, 0.79–0.95] per hour).
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a comparable effect size to what has been reported from 
randomized controlled trial data; (2) in contrast, the asso-
ciation between STA and TICI 2b-3 appears considerably 
weaker and is not consistent for other interventional end 
points (eg, TICI 2c/3); (3) patients with borderline indica-
tions not meeting early time window AHA/ASA guideline 
criteria were more likely to have prolonged ATG inter-
vals, probably reflecting difficulties in treatment decision-
making, which may also relate to pursuing the goal of 
TICI 2b-3 less rigorously; (4) even after correcting for 
such factors and other confounders (interventional tech-
nique, year of patient treatment) associated with pro-
longed ATG intervals, the effect of ATG on TICI 2b-3 
remained statistically robust; (5) in high-volume centers 
ATG intervals are quiet long, and associated factors like 
the use of MRI or general anesthesia, as well as patient 
characteristics associated with delays, have been identi-
fied as potential targets for improvement programs.
Achieving successful reperfusion remains the most 
important modifiable predictor of outcome in patients 
presenting with acute ischemic stroke due to large 
vessel occlusion. Accordingly, identifying factors asso-
ciated with decreased rates of successful reperfu-
sion is important. In our study, each hour of ATG delay 
was associated with a relative decrease of 13% in the 
odds of TICI 2b-3, comparing slightly lower than the 
22% odds reduction published by the HERMES col-
laboration.5 Our findings support that this association 
is not only true for selected randomized controlled 
trial patients but also tangible in a real-world cohort of 
patients with less restrictive inclusion criteria. We found 
a weak association between STA and rates of TICI 2b-3 
and observed a significant impact of STG interval on 
TICI 2b-3, although this effect seems mainly mediated 
by the association of ATG with TICI 2b-3.
One of the most important findings of the multicenter 
registry is that ATG intervals are quite long, with a median 
delay of 73 minutes. Allowing for varying effect sizes 
across centers, we were able to identify relevant factors 
associated with prolonged ATG intervals. These included 
the use of MRI and general anesthesia, as well as patient 
admission characteristics, such as low admission NIHSS, 
late presentation, and not meeting early time window 
AHA/ASA guideline criteria. Contrary to previous find-
ings,13 administration of intravenous tPA did not prolong 
the ATG interval. Even though treatment decisions in 
patients not meeting guideline criteria should be indi-
vidualized, there seems to be a significant delay in ATG 
intervals for those patients. To reduce such delays is 
not only important for improving patients outcome but 
Figure 2. Association of admission-to-groin-puncture (ATG) 
intervals with secondary procedural outcomes.
A significant effect of ATG was found regarding rates of first-pass 
Thrombolysis in Cerebral Infarction (FP TICI) 2c/3 (adjusted odds 
ratio, 0.87 [95% CI, 0.77–0.98]), while no significant associations 
were observed for all other secondary outcomes. sICH indicates 
symptomatic intracranial hemorrhage.
Figure 3. Adjusted differences in admission-to-groin-puncture (ATG) intervals according to baseline and procedural variables.
A, Categorical variables (effect scale, −60 to 60 min), patients receiving magnetic resonance imaging (MRI) or general anesthesia had increased 
ATG. B, Continuous variables (effect scale, −10 to 10 min), patients presenting late, patients with lower National Institutes of Health Stroke 
Scale (NIHSS), and patients treated in earlier years had increased ATG. C, Same model but functional dependence, age, Alberta Stroke Program 
Early CT Score (ASPECTS), admission NIHSS, and symptom-to-admission (STA) replaced by a compound variable of meeting American Heart 
Association (AHA)/American Stroke Association (ASA) guideline indication criteria. Patients meeting AHA/ASA guideline indication criteria on 
average had 14 min shorter ATG. CT indicates computed tomography; IV tPA, intravenous tissue-type plasminogen activator; M1, first segment of 
the middle cerebral artery; and M2, second segment of the middle cerebral artery. *Year of treatment implemented as continuous variable as per 
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should be kept in mind when evaluating the outcome of 
patients presenting with borderline criteria subjected to 
mechanical thrombectomy. This real-world data indicate 
that in these patients, potential beneficial effects may 
be masked by associated delays in ATG intervals and 
respective lower rates of achieving TICI 2b-3. Corrobo-
rating previous studies, the use of admission MRI was 
associated with in-hospital delays,14,15 further advocat-
ing the need for quality improvement program regarding 
sequence efficiency, as described recently.16
Several possible causal relations between prolonged 
ATG intervals and reduced rates of TICI 2b-3 have pre-
viously been discussed,5 such as thrombus modification 
over time (volume/extension,17 histological features18), 
which might influence mechanical reperfusion effi-
cacy.19,20 At first sight, however, this may be contradictive 
to the only small association between STA and TICI 2b-3 
because STA does usually constitute by far more of the 
time interval elapsed between symptom onset and the 
start of the intervention (≈2/3 in our cohort). Bourcier 
et al argued that the effect of STA may be diluted by 
uncertainties regarding the exact time point of symptom 
onset. Additionally, the authors argued that the effect of 
STA may be confounded by strict inclusion criteria of the 
randomized controlled trials (ie, only including patients 
with good collaterals, small infarct cores, incomplete 
occlusion pattern).5 The latter phenomenon concerning 
the effect of time on functional outcome, often referred 
to as the time-reset effect, is indeed well known: admis-
sion/imaging-to-groin intervals have a stronger asso-
ciation with outcome, as opposed to STA intervals, as 
also observed in this registry.21 Given the less restric-
tive selection criteria of our patient cohort, however, one 
would expect this bias to be weaker, thereby potentially 
unmasking an underlying association.
Our results provide evidence that prolonged ATG 
intervals are associated with borderline selection crite-
ria. In these cases, it is reasonable to assume that deci-
sion-making is generally prolonged. The grit to achieve 
successful reperfusion in borderline indications may per-
haps also diminish, which might explain decreased TICI 
2b-3 with increasing ATG. It is noteworthy that the asso-
ciation of ATG with TICI 2b-3 persisted after adjusting 
for confounding factors associated with prolonged ATG 
intervals. However, this does not necessarily imply the 
absence of more ill-defined residual confounding fac-
tors related to more complex decision-making, such as 
difficult vascular anatomy, questionable life expectancy/
comorbidities (cancer and dementia), or the search for 
a second/third opinion that may impede the dedication 
of subsequently pursuing TICI 2b-3 as rigorously as in 
more clear-cut cases.
Last, there is a paralleling development regarding 
improvements in rates of TICI 2b-3 and shorter ATG 
intervals in recent years following publication of the large 
randomized controlled trials in 2015. Hence, an associa-
tion of ATG with TICI 2b-3 may simply reflect this techni-
cal development or alternatively is a proxy reflecting that 
more experienced centers with presumingly shorter ATG 
also have higher rates of TICI 2b-3. However, correct-
ing for center and years of patient inclusion yielded a 
stable point estimate and 95% CI, suggesting that the 
association of ATG with rates of TICI 2b-3 is not merely 
explained by such technical developments or center-spe-
cific considerations.
Until further evidence becomes available, the causal 
relationship between prolonged ATG intervals and 
Figure 4. Association of admission-to-groin-puncture (ATG) intervals with probability of Thrombolysis in Cerebral Infarction 
(TICI) 2b-3 in various models.
A, Adjusted predicted probabilities of TICI 2b-3 with respect to increasing ATG intervals using model A (corresponding to the model used by 
Bourcier et al). B, Adjusted predicted probabilities of TICI 2b-3 applying a refined logistic regression model B, additionally adjusting for factors 
associated with increased ATG, stroke etiologic cause, interventional technique, and year of treatment (model B).
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reduced rates of TICI 2b-3 with only a minor impact of 
STA remains elusive. More focus is needed on decision-
making and workflow factors related to patients’ char-
acteristics and prolonged ATG intervals. Before such 
evidence becomes available, we do not know to what 
extent dawdling diminishes reperfusion or if prolonged 
ATG intervals relate to patient characteristics, where 
reperfusion is less often achieved or less rigorously pur-
sued to be achieved.
Strengths and Limitations
Strengths of this analysis are the large cohort of patients 
and increased sample sizes in subgroups thereby 
increasing statistical power, as well as adequate mod-
eling, enabling to explore factors associated with pro-
longed ATG intervals while correcting for confounders. 
Limitations of this study include a high percentage of 
incomplete complete workflow metrics and the retro-
spective nature of the registry. Most importantly, reper-
fusion success was not core laboratory adjudicated, 
impeding generalizability of the findings and comparabil-
ity across centers. While this may be especially relevant 
for differentiating TICI 2b and TICI 3,22 the agreement 
between operator and core laboratory for dichotomized 
TICI scores (ie, TICI 0/1/2a versus TICI 2b-3) is usu-
ally substantial22—an argument that supports the validity 
of our findings. Moreover, the association between pro-
longed ATG and reduced rates of, for example, TICI 2c/3 
or first-pass TICI 2c/3 are interesting but should be han-
dled with caution, since these variables were not defined 
as the primary outcome and, as secondary explorative 
analyses, are susceptible to α-error inflation.
Conclusions
There is a great potential to reduce ATG, and potential 
targets for improvement can be deduced from observa-
tional data. The association between in-hospital delay 
and reduced reperfusion rates is evident in real-world 
clinical data, underscoring the need to optimize in-hospi-
tal workflows. Given the only minor association between 
STA and reperfusion rates and controversial pathophysi-
ological considerations, the causal relationship of this 
association warrants further research.
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